Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Axiom is a premier healthcare marketing and medical communications agency that specializes in high-science brands within the pharmaceutical and biotechnology sectors. The company provides a comprehensive suite of strategic services, including brand development, medical education, and promotional marketing, designed to translate complex scientific data into compelling clinical narratives. Axiom is particularly recognized for its expertise in therapeutic areas such as oncology, rare diseases, and immunology, where deep scientific understanding is critical for effective healthcare professional engagement. In February 2022, Axiom was acquired by Lockwood, a leading global medical communications firm, to expand their collective reach and scientific capabilities. The agency continues to operate as a specialized unit, leveraging its clinical depth to support market success for global life science clients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Axiom Marketing Group.